Sanofi names Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs Ruchika Sharma22 Jun 2024 12:47 PM ISTParis: Sanofi has announced the appointment of Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France's President as...
Sanofi concludes acquisition of Inhibrx Ruchika Sharma2 Jun 2024 11:00 AM ISTParis: Sanofi has announced the completion of its acquisition of Inhibrx, Inc. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s...
USFDA requests additional data on Sanofi Dupixent for treating smoker's lung Ruchika Sharma31 May 2024 3:16 PM ISTParis: Sanofi and Regeneron have announced that the US Food and Drug Administration (FDA) requested additional efficacy analyses on the efficacy...
Sanofi Sarclisa accepted for USFDA priority review for transplant-ineligible newly diagnosed multiple myeloma Ruchika Sharma27 May 2024 11:30 AM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Sanofi, Formation Bio, OpenAI collaborate to build AI-powered software to accelerate drug development Ruchika Sharma21 May 2024 9:30 AM ISTParis: Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to...
Sanofi, Novavax ink pact to co-commercialize COVID vaccine, develop novel flu-COVID combination vaccines Ruchika Sharma12 May 2024 10:00 AM ISTParis: Sanofi has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US to develop...
Innate Pharma announces advancement of Sanofi-developed NK Cell Engager SAR443579/ IPH6101 progressing to Phase 2 for blood cancer patients Ruchika Sharma15 April 2024 3:17 PM ISTFrance: Innate Pharma SA has announced that the first patient was dosed in the Phase 2 dose expansion part of the Sanofi-sponsored clinical trial...
Sanofi new polio vaccine gets nod in India Ruchika Sharma6 April 2024 3:00 PM ISTNew Delhi: Drug giant Sanofi has received a nod for an alternative injectable vaccine, IMOVAX-Polio, to replace the widely used Inactivated Polio...
AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants Ruchika Sharma31 March 2024 12:30 PM ISTCambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of...
Dupixent application accepted for priority review by USFDA for COPD with type 2 inflammation Ruchika Sharma23 Feb 2024 4:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Sanofi consumer healthcare spin-off attracts private equity interest: Sources Ruchika Sharma21 Feb 2024 2:30 PM ISTLondon: Drugmaker Sanofi's consumer healthcare division has attracted interest from private equity funds as the French group prepares to spin out...
Sanofi Dupixent gets Japenese nod for chronic spontaneous urticaria Ruchika Sharma18 Feb 2024 10:00 AM ISTParis: Sanofi has announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization...
